Inhibitor Program Review: Dose Rate Versus Residual
A CO2 corrosion inhibitor is injected at 15 ppm into a 6-inch flowline carrying 8,000 bbl/d of produced water with 60,000 ppm chlorides, 0.8 mol% CO2, and 180 F. The vendor's recommended dose is 10-20 ppm. Coupons at the inlet show 0.2 mpy, but coupons at the outlet show 1.8 mpy. Residual inhibitor at the inlet is 8 ppm; at the outlet it is below detection. The line has a 2,000-foot horizontal run followed by a 500-foot vertical riser. The injection point is 50 feet from the wellhead. No pigging is performed. The operator wants to double the dose to 30 ppm to fix the outlet rate.
1. Is doubling the dose the right first response? Explain what the data indicate and what should be checked before changing dose.
Read the worked answer
Doubling the dose is not the right first response. The data point to a distribution and transport problem, not an insufficient dose at the injection point.
Evidence:
- Inlet residual 8 ppm with 0.2 mpy shows the chemical is effective where it is present.
- Outlet residual below detection with 1.8 mpy shows the inhibitor is not reaching the outlet - it is being consumed, adsorbed, or lost along the 2,000-foot run, or it is partitioning poorly in the high-chloride, high-temperature water.
- The vertical riser is a likely location for film thinning and higher shear, and without pigging, deposits can consume inhibitor and shield surfaces.
Before changing dose, check:
- Injection point location and mixing: 50 feet from the wellhead may be too close for good dispersion; consider moving it or adding a static mixer.
- Inhibitor partitioning and thermal stability at 180 F in 60,000 ppm chloride brine; some chemistries degrade or partition to the oil phase.
- Deposit and solids load; a pig run would show whether deposits are consuming chemical.
- Whether the outlet coupon is in a location with different flow regime (riser) than the inlet coupon.
Doubling dose without these checks may raise cost and still leave the outlet unprotected.
2. Design a field test to determine whether the outlet rate is dose-limited or distribution-limited.
Read the worked answer
A stepwise field test:
- Baseline: confirm current residuals and coupon rates at inlet, midpoint, and outlet over 2-4 weeks.
- Distribution test: keep dose at 15 ppm but add a tracer or use residual measurements at multiple points to map where the chemical is lost. If residual drops sharply over a short distance, distribution is the issue.
- Dose-response test: raise dose to 25-30 ppm for a defined period (e.g., 4-6 weeks) and measure residuals and coupon rates at the same points. If outlet residual rises and rate falls, the outlet was dose-limited; if outlet residual stays low and rate stays high, distribution is the cause.
- Mechanical test: run a pig and repeat residual mapping to see whether deposits were consuming inhibitor.
Interpretation rule: a rate improvement that tracks residual improvement supports dose limitation; a rate that does not improve despite higher dose supports distribution or mechanism change (e.g., under-deposit corrosion or erosion-corrosion in the riser). The test must be time-boxed and have pre-defined success criteria.
3. Recommend a final mitigation and monitoring plan, including how to justify the cost to management.
Read the worked answer
Final plan:
- Fix distribution first: relocate or add a mixing point, and establish a pigging program (monthly initially) to remove deposits and improve film contact.
- Optimize dose: after distribution is corrected, re-tune dose to the lowest rate that holds outlet residual above the target (e.g., 5 ppm) and outlet coupon below 1 mpy.
- Monitoring: coupons and ER probes at inlet, midpoint, and outlet; residual measurements at the same points; iron counts; and a follow-up review at 6 months.
Cost justification: compare the cost of the added chemical and pigging against the cost of a failure (repair, downtime, environmental release) and against the cost of over-dosing. The data show the chemical works where it reaches the surface, so the investment is in delivery, not in more chemical. Present the dose-response test results as the basis for the recommendation, and set a review trigger so the program is revisited if residuals or rates drift.